History and Current Status of Newborn Screening for Hemoglobinopathies

Seminars in Perinatology

Volumn 34, Issue 2, 2010, Pages 134-144

  Benson, Jane M ^a   Therrell Jr , Bradford L ^b  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

hemoglobinopathies; history; newborn screening; sickle cell disease

Indexed keywords

ALPHA GLOBIN; HEMOGLOBIN S; ORAL CONTRACEPTIVE AGENT; PENICILLIN G;

BACTEREMIA; BACTERIAL INFECTION; BLOOD SAMPLING; BLOOD TRANSFUSION; BRAIN INFARCTION; CHELATION THERAPY; CLINICAL LABORATORY; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; HEALTH CARE FINANCING; HEMOGLOBINOPATHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IRON OVERLOAD; ISOELECTRIC FOCUSING; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MUTATIONAL ANALYSIS; NEWBORN SCREENING; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEPTICEMIA; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; THALASSEMIA; UNITED STATES;

ANEMIA, SICKLE CELL; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; PRENATAL DIAGNOSIS; QUALITY ASSURANCE, HEALTH CARE; UNITED STATES;

EID: 77649123122     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2009.12.006     Document Type: Review

References (131)

1. Chernoff A.I., Fisher B., Harris J.W., et al. A system of nomenclature for the varieties of human hemoglobin. Science 118 (1953) 116-117
2. Giardine B., van Baal S., Kaimakis P., et al. HbVar database of human hemoglobin variants and thalassemia mutations: 2007 Update. Hum Mutat 28 (2007) 206-206
3. Newborn screening. Toward a uniform screening panel and system. Genet Med 8 suppl 1 (2006) 1S-252S
4. Embury S.H. Alpha thalassemia. A modifier of sickle cell disease. Ann NY Acad Sci 565 (1989) 213-221
5. Thein S.L. Genetic modifiers of the beta-haemoglobinopathies. Br J Haematol 141 (2008) 357-366
6. Embury S.H., Clark M.R., Monroy G., et al. Concurrent sickle cell anemia and alpha-thalassemia. Effect on pathological properties of sickle erythrocytes. J Clin Invest 73 (1984) 116-123
7. Gibbons R., Higgs D.R., Olivieri N.F., et al. The alpha thalassemias and their interaction with structural haemoglobin variants. In: Weatherall D.J., and Clegg J.B. (Eds). The Thalassemia Syndromes (2001), Blackwell, Science, Inc, Malden, MA 484-525
8. In: Noguchi L., Schechter A.N., Rodgers G.P., Higgs D.R., and Weatherall D.J. (Eds). Bailliere's Clinical Hematology: The Hemoglobinopathies (6) (1993), Bailliere Tindall, London 57-91
9. Bookchin R.M., Nagel R.L., and Ranney H.M. Structure and properties of hemoglobin C-Harlem, a human hemoglobin variant with amino acid substitutions in 2 residues of the beta-polypeptide chain. J Biol Chem 242 (1967) 248-255
10. Moo-Penn W.F., Schmidt R.M., Jue D.L., et al. Hemoglobin S Travis: a sickling hemoglobin with two amino acid substitutions [beta6(A3)glutamic acid leads to valine and beta142 (h20) alanine leads to valine). Eur J Biochem 77 (1977) 561-566
11. Moo-Penn W., Bechtel K., Jue D., et al. The presence of hemoglobin S and C Harlem in an individual in the United States. Blood 46 (1975) 363-367
12. Aksoy M. The hemoglobin E syndromes. II. Sickle-cell-hemoglobin E disease. Blood 15 (1960) 610-613
13. Singer K., Singer L., and Goldberg S.R. Studies on abnormal hemoglobins. XI. Sickle cell-thalassemia disease in the Negro; the significance of the S + A + F and S + A patterns obtained by hemoglobin analysis. Blood 10 (1955) 405-415
14. Vichinsky E. Hemoglobin E Syndromes. Hematology (2007) 79-83
15. Thein S.L. Pathophysiology of {beta} thalassemia-A Guide to molecular therapies. Hematology (2005) 31-37
16. Brittenham G., Schechter A., and Noguchi C. Hemoglobin S polymerization: primary determinant of the hemolytic and clinical severity of the sickling syndromes. Blood 65 (1985) 183-189
17. Herrick J.B. Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. 1910. Yale J Biol Med 74 (2001) 179-184
18. Itano H.A., and Pauling L. A rapid diagnostic test for sickle cell anemia. Blood 4 (1949) 66-68
19. Pauling L., and Itano H.A. Sickle cell anemia, a molecular disease. Science 109 (1949) 443
20. Nalbandian R.M., Nichols B.M., Camp Jr. F.R., et al. Automated dithionite test for rapid, inexpensive detection of hemoglobin S and non-S sickling hemoglobinopathies. Clin Chem 17 (1971) 1033-1037
21. Murayama M. Structure of sickle cell hemoglobin and molecular mechanism of the sickling phenomenon. Clin Chem 13 (1967) 578-588
22. Nalbandian R.M., Henry R.L., Nichols B.M., et al. Molecular basis for a simple, specific test for S hemoglobin: the Murayama test. Clin Chem 16 (1970) 945-950
23. Schmidt R.M., and Wilson S.M. Standardization in detection of abnormal hemoglobins. Solubility tests for hemoglobin S. JAMA 225 (1973) 1225-1230
24. Smithies O. Zone electrophoresis in starch gels: Group variations in the serum proteins of normal human adults. Biochem J 61 (1955) 629-641
25. Kohn J. Separation of haemoglobins on cellulose acetate. J Clin Pathol 22 (1969) 109-111
26. Schneider R.G. Electrophoretic methods in hemoglobin identifications. Hemoglobin 4 (1980) 521-526
27. Clegg J.B., Naughton M.A., and Weatherall D.J. An improved method for the characterization of human haemoglobin mutants: identification of alpha-2-beta-2-95GLU, haemoglobin N (Baltimore). Nature 207 (1965) 945-947
28. Drysdale J.W., Righetti P., and Bunn H.F. The separation of human and animal hemoglobins by isoelectric focusing in polyacrylamide gel. Biochim Biophys Acta 229 (1971) 42-50
29. Vesterberg O. Isoelectric focusing of proteins in polyacrylamide gels. Biochim Biophys Acta 257 (1972) 11-19
30. Huntsman R.G., Metters J.S., and Yawson G.I. The diagnosis of sickle cell disease in the newborn infant. J Pediatr 80 (1972) 279-281
31. Garrick M.D., Dembure P., and Guthrie R. Sickle-cell anemia and other hemoglobinopathies. Procedures and strategy for screening employing spots of blood on filter paper as specimens. N Engl J Med 288 (1973) 1265-1268
32. New York Public Health Laws 2500, in McKinney's Session Laws of New York, Chap 943, pp 1490 (1974)
33. New York Public Health Laws 2500, in McKinney's Session Laws of New York, Chap 1015, sect 1, pp 1624 (1974)
34. Pass K.A., Gauvreau A.C., Schedlbauer L., et al. Newborn screening for sickle cell disease. In: Carter T.P., and Wiley A.M. (Eds). Genetic Disease Screening and Management (1986), Alan R. Liss, New York, NY 359-372
35. Black J. Isoelectric focusing in agarose gel for detection and identification of hemoglobin variants. Hemoglobin 8 (1984) 117-127
36. Hempe J.M., Granger J.N., and Craver R.D. Capillary isoelectric focusing of hemoglobin variants in the pediatric clinical laboratory. Electrophoresis 18 (1997) 1785-1795
37. Lorey F., Cunningham G., Shafer F., et al. Universal screening for hemoglobinopathies using high-performance liquid chromatography: clinical results of 2. 2 Million screens. Eur J Hum Genet 2 (1994) 262-271
38. Michlitsch J., Azimi M., Hoppe C., et al. Newborn screening for hemoglobinopathies in California. Pediatr Blood Cancer 52 (2009) 486-490
39. Diggs L.W., and Flowers E. Sickle cell anemia in the home environment. Observations on the natural history of the disease in Tennessee children. Clin Pediatr 10 (1971) 697-700
40. Neel J.V. The inheritance of sickle cell anemia. Science 110 (1949) 64-66
41. Beet E.A. The genetics of sickle cell trait in a Bantu tribe. Ann Eugen 14 (1949) 279-284
42. Ingram V.M. Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin. Nature 180 (1957) 326-328
43. Guthrie R., and Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 32 (1963) 338-343
44. Perutz M.F. The hemoglobin molecule. Sci Am 211 (1964) 64-76
45. Scott R.B. Health care priority and sickle cell anemia. JAMA 214 (1970) 731-734
46. Scott R.B. Sickle-cell anemia-High prevalence and low priority. N Engl J Med 282 (1970) 164-165
47. Scott R.B. A commentary on sickle cell disease. J Natl Med Assoc 63 (1971) 1-2 passim
48. Reid C., and Rodgers G. Sickle cell disease: Demystifying the beginnings. In: Pace B.S. (Ed). Renaissance of Sickle Cell Disease Research in the Genomic Era (2007), World Scientific, London, Great Britain 1-12
49. Schmidt R.M. Hemoglobinopathy screening: approaches to diagnosis, education and counseling. Am J Public Health 64 (1974) 799-804
50. Schmidt R.M., and Brosious E.M. Basic Laboratory Methods of Hemoglobinopathy Detection (1972), DHEW, Atlanta, GA Vol. Publ: No. (CDC) 76-8266
51. Schmidt R.M., Moo-Penn W.F., and Brosious E.M. Advanced Laboratory Methods of Hemoglobinopathy Detection (1974), DHEW, Atlanta, GA Vol. Publ. Numbers 75-8296
52. Schmidt R.M., and Brosious E.M. Evaluation of proficiency in the performance of tests for abnormal hemoglobins. Am J Clin Pathol 62 (1974) 664-669
53. deJesus VR, Mei JV, Bell CJ, et al: Improving and assuring newborn screening laboratory quality worldwide: thirty-year experience at the Centers for Disease Control and Prevention. Semin Perinatol (in press)
54. Wilson S.M., and Schmidt R.M. Evaluation of a solubility test kit and an automated machine for detecting hemoglobin S. Clin Chem 20 (1974) 1138-1140
55. Schmidt R.M., Brosious E.M., and Holland S. Quantitation of fetal hemoglobin by densitometry. J Lab Clin Med 84 (1974) 740-745
56. Schmidt R.M., and Holland S. Standardization in abnormal hemoglobin detection. An evaluation of hemoglobin electrophoresis kits. Clin Chem 20 (1974) 591-594
57. Brosious E.M., Morrison B.Y., and Schmidt R.M. Effects of hemoglobin F levels, KCN, and storage on the isopropanol precipitation test for unstable hemoglobins. Am J Clin Pathol 66 (1976) 878-882
58. Brosious E.M., Wright J.M., Baine R.M., et al. Microchromatographic methods for hemoglobin A2 quantitation compared. Clin Chem 24 (1978) 2196-2199
59. Brosious E.M., and Schmidt R.M. Quantitation of hemoglobin F. An interlaboratory study. Am J Clin Pathol 72 (1979) 421-425
60. Schmidt R.M. Laboratory diagnosis of hemoglobinopathies. JAMA 224 (1973) 1276-1280
61. Schmidt R.M., Rucknagel D.L., and Necheles T.F. Comparison of methodologies for thalassemia screening by Hb A2 quantitation. J Lab Clin Med 86 (1975) 873-882
62. Schmidt R.M., Brosious E.M., Holland S., et al. Use of blood specimens collected on filter paper in screening for abnormal hemoglobins. Clin Chem 22 (1976) 685-687
63. Baine R.M., and Brown H.G. Evaluation of a commercial kit for microchromatographic quantitation of hemoglobin A2 in the presence of hemoglobin S. Clin Chem 27 (1981) 1244-1247
64. Huisman T.H., Schroeder W.A., Brodie A.N., et al. Microchromatography of hemoglobins. II. A simplified procedure for the determination of hemoglobin A2. J Lab Clin Med 86 (1975) 700-702
65. Singer K., Chernoff A.I., and Singer L. Studies on abnormal hemoglobins. II. Their identification by means of the method of fractional denaturation. Blood 6 (1951) 429-435
66. Betke K., Marti H.R., and Schlicht I. Estimation of small percentages of foetal haemoglobin. Nature 184 suppl 24 (1959) 1877-1878
67. Carrell R.W., and Kay R. A simple method for the detection of unstable haemoglobins. Br J Haematol 23 (1972) 615-619
68. Dacie J.V., Grimes A.J., Meisler A., et al. Hereditary Heinz-body anaemia. A report of studies on five patients with mild anaemia. Br J Haematol 10 (1964) 388-402
69. Grimes A.J., Meisler A., and Dacie J.V. Congenital Heinz-body anaemia. Further evidence on the cause of Heinz-body production in red cells. Br J Haematol 10 (1964) 281-290
70. Rigas D.A., and Koler R.D. Decreased erythrocyte survival in hemoglobin H disease as a result of the abnormal properties of hemoglobin H: the benefit of splenectomy. Blood 18 (1961) 1-17
71. Koepke J.A., Thoma J.F., and Schmidt R.M. Identification of human hemoglobins by use of isoelectric focusing in gel. Clin Chem 21 (1975) 1953-1955
72. Baiget M., Gomez Pereira C., Jue D.L., et al. A case of hemoglobin Indianapolis [beta 112(G14) Cys-Arg] in an individual from Cordoba, Spain. Hemoglobin 10 (1986) 483-494
73. Ballas S.K., Park D., Fernandez L., et al. Erythrocytosis secondary to HB Bunbury [alpha 2 beta (2)94(FG1)Asp-Asn]. Hemoglobin 16 (1992) 281-286
74. Bonaventura J., Bonaventura C., Sullivan B., et al. Hemoglobin Providence. Functional consequences of two alterations of the 2,3-diphosphoglycerate binding site at position beta 82. J Biol Chem 251 (1976) 7563-7571
75. Bonaventura C., Arumugam M., Cashon R., et al. Chloride masks effects of opposing positive charges in Hb A and Hb Hinsdale (beta 139 Asn->Lys) that can modulate cooperativity as well as oxygen affinity. J Mol Biol 239 (1994) 561-568
76. McDonald M.J., Michalski L.A., Turci S.M., et al. Structural, functional, and subunit assembly properties of hemoglobin Attleboro [alpha 138 (H21) Ser-Pro], a variant possessing a site maturation at a critical C-terminal residue. Biochemistry 29 (1990) 173-178
77. Moo-Penn W.F., Bechtel K.C., Schmidt R.M., et al. Hemoglobin Raleigh (beta1 valine replaced by acetylalanine). Structural and functional characterization. Biochemistry 16 (1977) 4872-4879
78. Moo-Penn W.F., McPhedran P., Bobrow S., et al. Hemoglobin Connecticut (beta 21 (B3) Asp leads to Gly): a hemoglobin variant with low oxygen affinity. Am J Hematol 11 (1981) 137-145
79. Moo-Penn W.F., Jue D.L., Johnson M.H., et al. Structural and functional studies of hemoglobin Wayne: an elongated alpha-chain variant. J Mol Biol 180 (1984) 1119-1140
80. Turner G.J., Galacteros F., Doyle M.L., et al. Mutagenic dissection of hemoglobin cooperativity: effects of amino acid alteration on subunit assembly of oxy and deoxy tetramers. Proteins 14 (1992) 333-350
81. Winslow R.M. Laboratory Methods for Detecting Hemoglobinopathies (1984), Department of Health and Human Services (Centers for Disease Control and Prevention), Atlanta
82. Schmidt R.M., Brosious E.M., and Wright J.M. Preparation and use of a quality control hemolysate for microchromatographic determinations of hemoglobin A2. Am J Clin Pathol 67 (1977) 215-218
83. Gaston M., and Rosse W.F. The cooperative study of sickle cell disease: review of study design and objectives. Am J Pediatr Hematol/Oncol 4 (1982) 197-201
84. Gaston M.H., Verter J.I., Woods G., et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 314 (1986) 1593-1599
85. Consensus conference. Newborn screening for sickle cell disease and other hemoglobinopathies. JAMA 258 (1987) 1205-1209
86. Lloyd-Puryear M.A., Therrell B.L., Mann M.Y., et al. The role of the federal government in supporting newborn screening programs. In: Baily M.A., and Murray T.H. (Eds). Ethics in Newborn Screening: New Technologies, New Challenges (2009), Johns Hopkins University Press, Baltimore, MD 178-194
87. Therrell B.L., Johnson A., and Williams D. Status of NBS programs in the United States. In: Schmidt B.J., Diament A.J., and Loghin-Grosso N.S. (Eds). Current Trends in Infant Screening (1988), Elsevier Science, Amsterdam 331-337
88. Platt O.S., Thorington B.D., Brambilla D.J., et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 325 (1991) 11-16
89. Kinney T.R., Sleeper L.A., Wang W.C., et al. Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The cooperative study of sickle cell disease. Pediatrics 103 (1999) 640-645
90. Smith L.A., Oyeku S.O., Homer C., et al. Sickle cell disease: a question of equity and quality. Pediatrics 117 (2006) 1763-1770
91. Kan Y.W., Golbus M.S., and Trecartin R. Prenatal diagnosis of sickle-cell anemia. N Engl J Med 294 (1976) 1039-1040
92. Kan Y.W., and Dozy A.M. Antenatal diagnosis of sickle-cell anaemia by DNA analysis of amniotic-fluid cells. Lancet 2 (1978) 910-912
93. Kan Y.W., and Dozy A.M. Polymorphism of DNA sequence adjacent to human beta-globin structural gene: relationship to sickle mutation. Proc Natl Acad Sci U S A 75 (1978) 5631-5635
94. Chang J.C., and Kan Y.W. Antenatal diagnosis of sickle cell anaemia by direct analysis of the sickle mutation. Lancet 2 (1981) 1127-1129
95. Saiki R.K., Scharf S., Faloona F., et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230 (1985) 1350-1354
96. Mullis K., Faloona F., Scharf S., et al. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb Symp Quant Biol 51 (1986) 263-273
97. Wong C., Dowling C.E., Saiki R.K., et al. Characterization of beta-thalassaemia mutations using direct genomic sequencing of amplified single copy DNA. Nature 330 (1987) 384-386
98. McCabe E.R., Huang S.Z., Seltzer W.K., et al. DNA microextraction from dried blood spots on filter paper blotters: potential applications to newborn screening. Hum Genet 75 (1987) 213-216
99. Saiki R.K., Gelfand D.H., Stoffel S., et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239 (1988) 487-491
100. Saiki R.K., Chang C.A., Levenson C.H., et al. Diagnosis of sickle cell anemia and beta-thalassemia with enzymatically amplified DNA and nonradioactive allele-specific oligonucleotide probes. N Engl J Med 319 (1988) 537-541
101. Jinks D.C., Minter M., Tarver D.A., et al. Molecular genetic diagnosis of sickle cell disease using dried blood specimens on blotters used for newborn screening. Hum Genet 81 (1989) 363-366
102. McCabe E.R., Zhang Y.H., Descartes M., et al. Rapid detection of beta s DNA from Guthrie cards by chromogenic probes. Lancet 2 (1989) 741
103. Descartes M., Huang Y., Zhang Y.H., et al. Genotypic confirmation from the original dried blood specimens in a neonatal hemoglobinopathy screening program. Pediatr Res 31 (1992) 217-221
104. Zhang Y.H., and McCabe E.R. Analysis from newborn screening dried blood specimens. Hum Genet 89 (1992) 311-314
105. Sylvester-Jackson D.A., Page S.L., White J.M., et al. Unbiased analysis of the frequency of beta-thalassemia point mutations in a population of African-American newborns. Arch Pathol Lab Med 117 (1993) 1110-1114
106. Zhang Y.H., McCabe L.L., Wilborn M., et al. Application of molecular genetics in public health: improved follow-up in a neonatal hemoglobinopathy screening program. Biochem Med Metab Biol 52 (1994) 27-35
107. Bhardwaj U., Zhang Y.H., and McCabe E.R. Neonatal hemoglobinopathy screening: molecular genetic technologies. Mol Genet Metab 80 (2003) 129-137
108. Sutcharitchan P., and Embury S.H. Advances in molecular diagnosis of inherited hemoglobin disorders. Curr Opin Hematol 3 (1996) 131-138
109. Dunbar S. Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection. Clin Chim Acta 363 (2006) 71-82
110. Strom C., Janeszco R., Quan F., et al. Technical validation of a TM biosciences Luminex-based multiplex assay for detecting the American College of Medical Genetics recommended cystic fibrosis mutation panel. J Mol Diagn 8 (2006) 371-375
111. Aslanian S., Azimi M., Noble J., et al. Application of flow cytometry-based genotyping for rapid detection of hemoglobin variants. Int J Lab Hematol 29 (2007) 284-291
112. Austin H., Key N.S., Benson J.M., et al. Sickle cell trait and the risk of venous thromboembolism among blacks. Blood 110 (2007) 908-912
113. Vrettou C., Traeger-Synodinos J., Tzetis M., et al. Rapid screening of multiple {beta}-globin gene mutations by real-time PCR on the LightCycler: application to carrier screening and prenatal diagnosis of thalassemia syndromes. Clin Chem 49 (2003) 769-776
114. Steinberg K., and Gallagher M. Methods for assessing genotypes in human genome epidemiology studies. In: Khoury M.J., Little J., and Burke W. (Eds). Human Genome Epidemiology: A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease (2003), Oxford University Press, New York, NY 79-91
115. Creary L.E., Ulug P., Menzel S., et al. Genetic variation on chromosome 6 influences F cell levels in healthy individuals of African descent and HbF levels in sickle cell patients. PLoS One 4 (2009) e4218
116. Menzel S., and Thein S.L. Genetic architecture of hemoglobin F control. Curr Opin Hematol 16 (2009) 179-186
117. Steinberg M.H. Predicting clinical severity in sickle cell anaemia. Br J Haematol 129 (2005) 465-481
118. Steinberg M. Genetic etiologies for phenotypic diversity in sickle cell anemia. ScientificWorldJournal 9 (2009) 46-67
119. Sebastiani P., Timofeev N., Dworkis D., et al. Genome-wide association studies and the genetic dissection of complex traits. Am J Hematol 84 (2009) 504-515
120. Howell RR, Lloyd-Puryear M: From developing guidelines to implementing legislation: actions of the U.S. Advisory Committee on Heritable Disorders in newborns and children towards advancing and improving newborn screening. Semin Perinatol (in press)
121. Falletta J.M., Woods G.M., Verter J.I., et al. Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic penicillin study II. J Pediatr 127 (1995) 685-690
122. Kolnagou A., and Kontoghiorghes G. Advances in the prevention and treatment are changing thalassemia from a fatal to a chronic disease. Experience from a Cyprus model and its use as a paradigm for future applications. Hemoglobin 33 (2009) 287-295
123. Ault P., and Jones K. Understanding iron overload: Screening, monitoring, and caring for patients with transfusion-dependent anemias. Clin J Oncol Nurs 13 (2009) 511-517
124. Austin H., Lally C., Benson J.M., et al. Hormonal contraception, sickle cell trait, and risk for venous thromboembolism among African American women. Am J Obstet Gynecol 200 (2009) e1-e3
125. Schnedl W.J., Krause R., Halwachs-Baumann G., et al. Evaluation of HbA1c determination methods in patients with hemoglobinopathies. Diabetes Care 23 (2000) 339-344
126. Wiwanitkit V. Problem of using hemoglobin A1C measurement in endemic area of hemoglobinopathy. Prim Care Diabetes 1 (2007) 173-175
127. Schnedl W.J., Trinker M., and Lipp R.W. HbA1c determination in patients with hemoglobinopathies. Diabetes Care 22 (1999) 368-369
128. Miller R., Segal J., Ashar B., et al. High prevalence and correlates of low bone mineral density in young adults with sickle cell disease. Am J Hematol 81 (2006) 236-241
129. Kark J.A., Posey D.M., Schumacher H.R., et al. Sickle-cell trait as a risk factor for sudden death in physical training. N Engl J Med 317 (1987) 781-787
130. Tsaras G., Owusu-Ansah A., Boateng F., et al. Complications associated with sickle cell trait: a brief narrative review. Am J Med 122 (2009) 507-512
131. Weatherall D.J., and Clegg J.B. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ 79 (2001) 704-712